Back to MAZE

CITADEL ADVISORS LLC → MAZE

CITADEL ADVISORS LLC MAZE Position History

Maze Therapeutics, Inc. • Healthcare

Quarters held
12
Latest value
$286K
Q2 2026
Peak value
$21.1M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$21.1M
Q1 2026$257K
Q1 2026$2.1M
Q1 2026$743K
Q2 2026$18.8M
Q2 2026$376K
Q2 2026$6.7M
Q2 2026$286K
Q2 2026$18.8M
Q2 2026$376K
Q2 2026$6.7M
Q2 2026$286K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$286K9.6K——
Q2 2026$6.7M223.9K——
Q2 2026$376K12.6K——
Q2 2026$18.8M628.8K——
Q2 2026$286K9.6K——
Q2 2026$6.7M223.9K——
Q2 2026$376K12.6K——
Q2 2026$18.8M628.8K——
Q1 2026$743K24.9K——
Q1 2026$2.1M70.4K——
Q1 2026$257K8.6K——
Q1 2026$21.1M705.4K——

Other funds holding MAZE

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
SPY

SPDR S&P 500 ETF TR

$3B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
NVDA

NVIDIA CORPORATION

$2.1B
SPY

SPDR S&P 500 ETF TR

$2.1B
NVDA

NVIDIA CORPORATION

$2.1B